INFLAMMATION BIOMARKER

The present invention relates to biomarkers of inflammation and particularly, although not exclusively, to biomarkers of inflammatory bowel disease. Methods useful for the clinical management of patients with inflammatory bowel disease (IBD) are provided, and particularly methods for distinguishing...

Full description

Saved in:
Bibliographic Details
Main Authors MCLAUGHLIN, John Thomas, BRAMHALL, Michael Lyell, CRUICKSHANK, Sheena, BRASS, Andrew Michael
Format Patent
LanguageEnglish
French
Published 31.08.2017
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to biomarkers of inflammation and particularly, although not exclusively, to biomarkers of inflammatory bowel disease. Methods useful for the clinical management of patients with inflammatory bowel disease (IBD) are provided, and particularly methods for distinguishing between acute resolving inflammation and chronic inflammation, based on the presence, absence or elevation of a biomarker. La présente invention concerne des biomarqueurs d'inflammation, notamment, mais non exclusivement, des biomarqueurs de maladie intestinale inflammatoire. L'invention concerne également des méthodes utiles à la gestion clinique de patients atteints de maladie intestinale inflammatoire (IBD) et, particulièrement, des méthodes permettant de distinguer une inflammation de résolution aiguë d'une inflammation chronique, sur la base de la présence, de l'absence ou de l'élévation d'un biomarqueur.
Bibliography:Application Number: WO2017EP53956